Female Genital Tuberculosis Diagnosis to Treatment
Journal Title: Pan Asian Journal of Obstetrics & Gynecology - Year 2018, Vol 1, Issue 2
Abstract
Genital tuberculosis in females (FGTB) is a significant cause of morbidity. Mycobacterium tuberculosis is a causative agent for tuberculosis (TB). In majority of cases tubes are involved in almost 90-100% of cases. Endometrium is the next commonly involved organ (50-80%), ovarian involvement is seen in 20-30% of cases followed by cervical involvement (5-15%). Vulva and vagina are rarely involved (1-2%). Diagnosis of FGTB is traditionally made by the presence of tubercular bacilli on microscopic examination or culture of endometrial biopsy specimen or granuloma in histopathological examination. Polymerase chain reaction have false positive results and as an isolated test it is not enough to detect the condition. Gold standard investigation for the diagnosis of FGTB is hysteroscopy and laparoscopy. Genital tuberculosis falls under category 1 of Directly Observed Treatment Short Course (DOTS) treatment and antitubercular treatment is given for 6 months. Therapy consist of initial 2 months of rifampicin, isoniazid, pyrazinamide and ethambutol and 4 months treatment with two drugs i.e. rifampicin and isoniazid. Surgical treatment has a very limited role, particularly for the drainage of residual tubercular abscess
Authors and Affiliations
Neha Varun
Keywords
Related Articles
- EP ID EP546230
- DOI -
- Views 158
- Downloads 0
Fetal Interventions and Fetal Diagnostic Tests—When to Order What
The major aim of prenatal diagnosis is prevention of mental and physical handicap. This involves both low risk women without any family history and high risk women who have a family history of a child with malformations,...
Silent Perforation of Pyometra Resulting in an Acute Abdomen: A Rare Entity
Pyometra refers to collection of pus in uterine cavity. It is an extremely rare condition. This case report gives insight into the management of an unusal case of spontaneous perforation of pyometra in a 55-year-old post...
Snapshot of an Improved Maternal Health in India: The Pillars of Strength
Maternal health has been a priority in India with the maternal health programs evolving over time. The maternal mortality ratio has decreased tremendously and India’s journey in decline of maternal mortality is a story w...
Luteal Phase Support: Why, When and How
Luteal phase support (LPS) is a known intervention for preventing the pregnancy loss. It is most commonly used in the artificial reproduction cycles. Most common agent used for the LPS is progesterone. Current review dis...
Umbilical Coiling Index: An Important Predictor of Fetal Outcome
Umbilical cord is an important structure for fetal survival. Any abnormality of the umbilical cord can lead to fetal distress, growth restriction and intrauterine death. A rare case of long cord with high umbilical coili...